For pharma and medtech

Your teams have AI. Your customers have doctors.

I have spoken for most of the large European pharma and medtech organisations, and I build software that sits in the hospitals your customers work in. That combination is why medical affairs teams book me for physician audiences.

What pharma teams keep running into

Enablement that stops at the tool

Global mandates a platform, the affiliate runs a training, usage spikes and then flattens. Nothing in the enablement told anyone which of their actual tasks to hand over and which to keep.

A physician audience that can smell a deck

Speak to clinicians about AI without clinical standing and you lose the room in ninety seconds. This is the single most common reason a well-funded HCP event underperforms.

Medical, legal and regulatory as an afterthought

The interesting AI use cases in medical affairs live exactly where MLR review, the EU AI Act and GDPR intersect. Sessions that ignore that produce enthusiasm nobody can act on.

Talks for this audience
01

The AI is installed. Almost nobody uses it.

Why adoption stalls, and what the organisations where it worked did differently.

EN · DE · FR

The gap between AI that is bought and AI that is used, taken apart with real numbers from real deployments — including the ones that failed. Built for an audience that has already spent money and wants to know why the return has not arrived.

What the room leaves with
  • The four frictions that account for most stalled adoption, and which one is yours
  • Why the pilot that succeeded is often the reason the rollout failed
  • A test for telling genuine productivity from displaced work
02

When being wrong is expensive.

AI in industries that cannot move fast and break things.

EN · DE · FR

Built for regulated sectors: how to design an AI capability that a supervisor, an auditor or a court can inspect afterwards — without governance so heavy that the work goes underground. Uses GDPR and the EU AI Act as concrete cases rather than a compliance lecture.

What the room leaves with
  • Governance as a lane instead of a gate, with the design rules that make it one
  • The four production constraints that kill sandbox projects, known up front
  • How to tell a real regulatory blocker from an inherited assumption
03

The work around the model.

What people are actually for once the machine can do the middle of the task.

EN · DE · FR

The talk that started all of this, and the one most often requested for mixed audiences. Framing, context, judgement, integration — the four things that stay human, made concrete enough to practise. Written for a general professional audience without becoming a general talk.

What the room leaves with
  • The four-part description of the human half of the work, with examples from your sector
  • Why prompt engineering is the easy, boring part
  • One habit to start on Monday, and one to stop
An intelligent mix of practical examples and scientifically grounded knowledge — refreshing.
SVPRoche Diagnostics Germany
Spoken for
Written on this

Why Interdisciplinary Teams Keep Arriving at Obvious Answers

A 1985 experiment showed groups discuss what they share, not what they know — and quietly erase the diversity they were assembled to combine.

Read the essay →

Next step

Cycle meetings, kickoffs, HCP events.

Delivered in German, English or French, with the compliance constraints understood before the brief comes back.